|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0004793,
umls-concept:C0017337,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0332291,
umls-concept:C0376495,
umls-concept:C0524910,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1999-10-20
|
|
pubmed:abstractText |
Interferon-alpha plus ribavirin is an effective treatment for chronic hepatitis C patients. We evaluated whether the response to this combined therapy correlated with the presence of mutations in a region of 372 nucleotides within the NS5A gene.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2487-95
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10484013-Adult,
pubmed-meshheading:10484013-Antiviral Agents,
pubmed-meshheading:10484013-Base Sequence,
pubmed-meshheading:10484013-Drug Therapy, Combination,
pubmed-meshheading:10484013-Female,
pubmed-meshheading:10484013-Hepatitis C, Chronic,
pubmed-meshheading:10484013-Humans,
pubmed-meshheading:10484013-Interferon-alpha,
pubmed-meshheading:10484013-Male,
pubmed-meshheading:10484013-Middle Aged,
pubmed-meshheading:10484013-Molecular Sequence Data,
pubmed-meshheading:10484013-Predictive Value of Tests,
pubmed-meshheading:10484013-RNA Replicase,
pubmed-meshheading:10484013-Recombinant Proteins,
pubmed-meshheading:10484013-Ribavirin,
pubmed-meshheading:10484013-Treatment Outcome,
pubmed-meshheading:10484013-Viral Nonstructural Proteins
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Response to retreatment with interferon-alpha plus ribavirin in chronic hepatitis C patients is independent of the NS5A gene nucleotide sequence.
|
|
pubmed:affiliation |
Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
